drugset / Trial / NCT03315494
Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
This double-blind, placebo-controlled, multiple ascending dose study is designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of SKI-O-703 in healthy volunteers.
Timeline
- Start
- 2016-09-22
- Primary completion
- 2016-12-21
- Completion
- 2016-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SKI-O-703 | Unknown | 200 mg | Oral |
| Subject | SKI-O-703 | Unknown | 400 mg | Oral |